OUR RESOURCES
Video and slides 
CRSF Asco list of publications 
Ongoing studies Lung Cancer Treatment Updates On 14 Oct
Webinar - Lung Cancer Treatment Updates On 14 Oct 2022
Welcome & Introduction
Role of Alecensa in 1L ALK+ NSCLC patients Beyond The Barriers
Real World Evidence Osimertinib as SoC in the management of EGFRm NSCLC
Time to target MET in NSCLC
Optimizing Tratment For First-line NSCLC
Case based Panel discussion
Closing Remarks